case_images: PMC7675892_01
case_images: Images of the lesion changes reflected the therapeutic response following Olaparib therapy. The waist lesion can be observed from the body surface and reduced after therapy (left column). CT images show that the waist lesion reduced following Olaparib therapy (middle column, arrows indicate the lesion). CT images show that the pelvic lesion reduced following Olaparib therapy (right column, arrows indicate the lesion).. CT, computed tomography.
case_images: 10.1177_1758835920970845-fig1.jpg
case_images: PMC7675892_01_10.1177_1758835920970845-fig1.jpg
case_images: fig1-1758835920970845
case_images: Computed tomography (CT) examination showed a slightly high-density soft tissue mass shadow of 3.2 x 3.1 cm on the posterior wall of the left abdomen, a dense soft tissue mass shadow on the left internal iliac lymph nodes (3.2 x 4.2 cm, thick-walled annular enhancement in contrast-enhanced CT), and multiple enlarged lymph nodes to the left of the abdominal aorta (maximum diameter of about 1.5 cm) (Figure 1 before therapy). The patient's left back pain later worsened, accompanied by a loss of appetite, and a "goose egg" size mass was found at the left waist (Figure 1 before therapy). At 3 months after the initiation of Olaparib therapy, CT reexamination revealed a reduction of the left lumbar mass (Figure 1 after therapy) and a reduction of the abnormal enhanced mass in the original left kidney area (Figure 1 after therapy).